Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
591 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06574022 | Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks | recruiting | Phase 4 | 100 | University of CincinnatiOTHER | 1 | Nov 4, 2025 | clinicaltrials |
| NCT03229200 | Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. | active not recruiting | Phase 4 | 297 | Pharmacyclics Switzerland GmbHINDUSTRY | 17 | Oct 30, 2025 | clinicaltrials |
| NCT06218823 | Tobacco Treatment Comparison for Cancer Care | completed | Phase 4 | 52 | University of Wisconsin, MadisonOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT05919329 | Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy | recruiting | Phase 4 | 80 | OHSU Knight Cancer InstituteOTHER | 1 | Oct 24, 2025 | clinicaltrials |
| NCT07215000 | Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial(COOP SIT) | recruiting | Phase 4 | 300 | Morehouse School of MedicineOTHER | 1 | Oct 9, 2025 | clinicaltrials |
| NCT07189897 | Apixaban or Enoxaparin After Head and Neck Cancer Surgery | recruiting | Phase 4 | 76 | Kiranya ArnoldOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT01496313 | To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer | completed | Phase 4 | 81 | SanofiINDUSTRY | 9 | Oct 3, 2025 | clinicaltrials |
| NCT03244020 | LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology | enrolling by invitation | Phase 4 | 2,868 | Massachusetts General HospitalOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT04319198 | Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy | completed | Phase 4 | 25 | Gilead SciencesINDUSTRY | 3 | Sep 30, 2025 | clinicaltrials |
| NCT05807074 | Impact of Topical Tranexamic Acid in Breast Reconstruction | terminated | Phase 4 | 23 | University of California, San FranciscoOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT07124351 | Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) | recruiting | Phase 4 | 15 | Cedars-Sinai Medical CenterOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT06074510 | PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer(MIRROR) | active not recruiting | Phase 4 | 274 | Lantheus Medical ImagingINDUSTRY | 1 | Sep 11, 2025 | clinicaltrials |
| NCT06289192 | Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community | completed | Phase 4 | 5 | Johns Hopkins UniversityOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT04038255 | Mindfulness Based Smoking Cessation Among Cancer Survivors | terminated | Phase 4 | 20 | University of MiamiOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT05342883 | GammaTile and Stupp in Newly Diagnosed GBM(GESTALT) | active not recruiting | Phase 4 | 61 | GT Medical Technologies, Inc.INDUSTRY | 1 | Sep 5, 2025 | clinicaltrials |
| NCT02670161 | Quality Improvement and Practice Based Research in Neurology Using the EMR | enrolling by invitation | Phase 4 | 3,300 | Endeavor HealthOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT03315975 | Flu Vaccine Responses in the Setting of Melanoma Treatment | active not recruiting | Phase 4 | 40 | University of PennsylvaniaOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT00463580 | A Study of Infliximab for Treatment Resistant Major Depression(Infliximab) | completed | Phase 4 | 60 | Emory UniversityOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT05294640 | Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures | completed | Phase 4 | 95 | University of California, San FranciscoOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT02078726 | Glucagon Use in Colonoscopies | completed | Phase 4 | 100 | University of California, San FranciscoOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT02500147 | Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) | terminated | Phase 4 | 3 | Columbia UniversityOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT03955991 | VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer)(VSMART) | completed | Phase 4 | 109 | University of MiamiOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT04489888 | A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10) | completed | Phase 4 | 101 | Merck Sharp & Dohme LLCINDUSTRY | 5 | Jun 19, 2025 | clinicaltrials |
| NCT03360214 | PEMF and PEC Blocks in Mastectomy Reconstruction Patients | completed | Phase 4 | 60 | Columbia UniversityOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT04362072 | Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer | completed | Phase 4 | 71 | PfizerINDUSTRY | 7 | Jun 11, 2025 | clinicaltrials |
| NCT05805436 | Preop Laxatives in Robotic Urologic Surgery | recruiting | Phase 4 | 240 | Chad R. TracyOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT04347122 | Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction | terminated | Phase 4 | 12 | University of Kansas Medical CenterOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06077487 | Ketamine-assisted Therapy for Advanced GI Cancer | terminated | Phase 4 | 1 | Brian Anderson, MDOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT04506086 | Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) | terminated | Phase 4 | 10 | AmgenINDUSTRY | 1 | May 18, 2025 | clinicaltrials |
| NCT05178303 | Composition for Treating Cirrhosis and Liver Cancer (SB-1121)(SB-1121) | completed | Phase 4 | 134 | Nguyen Thi Trieu, MDINDIV | 2 | May 16, 2025 | clinicaltrials |
| NCT03289741 | A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide | completed | Phase 4 | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT01490892 | Quantitative Subharmonic Breast Imaging | completed | Phase 4 | 219 | Thomas Jefferson UniversityOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03034096 | General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial(GA-CARES) | completed | Phase 4 | 1,826 | Stony Brook UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT06834386 | Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients | withdrawn | Phase 4 | 0 | Mayo ClinicOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT05266898 | Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV(AGO-Gard) | recruiting | Phase 4 | 250 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT05206448 | Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation(CLC II) | active not recruiting | Phase 4 | 190 | Rachel MejiaOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT05108805 | Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting | completed | Phase 4 | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT02312960 | Radium-223 Dichloride Long-term Follow-up Program | completed | Phase 4 | 255 | BayerINDUSTRY | 22 | Mar 25, 2025 | clinicaltrials |
| NCT04060654 | SUBLOCADE Rapid Initiation Extension Study | completed | Phase 4 | 17 | Indivior Inc.INDUSTRY | 1 | Mar 25, 2025 | clinicaltrials |
| NCT04080531 | Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders | completed | Phase 4 | 165 | Emory UniversityOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT03167281 | Early Intrapleural TPA Instillation Versus Late(ELEVATE) | withdrawn | Phase 4 | 0 | Prisma Health-MidlandsOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06806410 | The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery | active not recruiting | Phase 4 | 120 | St. Luke's Hospital, PennsylvaniaOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT02853500 | Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies | withdrawn | Phase 4 | 0 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT03298945 | Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens | completed | Phase 4 | 2,239 | VA Office of Research and DevelopmentFED | 1 | Feb 5, 2025 | clinicaltrials |
| NCT01804166 | A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) | completed | Phase 4 | 1 | Janssen Scientific Affairs, LLCINDUSTRY | 1 | Feb 4, 2025 | clinicaltrials |
| NCT05848947 | SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA(MAApping) | completed | Phase 4 | 5 | Sirtex MedicalINDUSTRY | 1 | Jan 29, 2025 | clinicaltrials |
| NCT04134208 | An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer | terminated | Phase 4 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 16, 2025 | clinicaltrials |
| NCT06164392 | Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography | withdrawn | Phase 4 | 0 | Northwestern UniversityOTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT05717400 | Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy | terminated | Phase 4 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT04526704 | Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib(PLX3397) | completed | Phase 4 | 32 | Daiichi SankyoINDUSTRY | 7 | Dec 30, 2024 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials